SCHEMBL14650720

SCHEMBL14650720

Cc1cc(C)c2c(N)c(C(=O)Nc3ccccc3F)sc2c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.66
RAB9A P51151 6/20 0.66
MEN1 O00255 5/20 0.66
KMT2A Q03164 5/20 0.66
L3MBTL1 Q9Y468 1/20 0.53
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
TDP1 Q9NUW8 2/20 0.49
PTPN7 P35236 1/20 0.49
MAPT P10636 3/20 0.49
NR1I2 O75469 1/20 0.49
AHR P35869 1/20 0.49
USP2 O75604 1/20 0.48
LMNA P02545 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
TP53 P04637 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL424894 0.80 NPC1 (1.00) NPC1RAB9AMEN1KMT2AL3MBTL1
SCHEMBL14955713 0.68 MAPT (0.74) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL13186367 0.67 TP53 (0.66) NPC1RAB9AMEN1KMT2AL3MBTL1
SCHEMBL16071464 0.67 MAPT (0.66) NPC1RAB9AMEN1KMT2AL3MBTL1
SCHEMBL2248037 0.66 F10 (0.69) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL10016378 0.66 NPC1 (0.76) NPC1RAB9AMEN1KMT2AL3MBTL1
SCHEMBL426549 0.65 MAPT (0.63) NPC1RAB9AMEN1KMT2AL3MBTL1
SCHEMBL425769 0.65 MEN1 (0.77) NPC1RAB9AMEN1KMT2AL3MBTL1
SCHEMBL24886328 0.65 RAB9A (0.71) NPC1RAB9AMEN1KMT2AL3MBTL1
SCHEMBL17772176 0.65 HTT (0.63) NPC1RAB9AMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130023498-A1 MicroRNA Modulators and Method for Identifying and Using the Same The Wistar Institute and North Carolina State University 2013-01-24 US disclosed
US-20130023498-A1 MicroRNA Modulators and Method for Identifying and Using the Same The Wistar Institute and North Carolina State University 2013-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130023498-A1 MicroRNA Modulators and Method for Identifying and Using the Same AGO2, RNASE1, TRDMT1 NPC1 667/4885RAB9A 2435/4885MEN1 1708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.